Columbus
Real Health
Broadly Neutralizing Antibodies Help Kids Control HIV
Broadly neutralizing antibodies (bnAbs), which recognize multiple strains of HIV, show promise as a treatment for children when used in combination with standard antiretroviral therapy, according to research published in Science Translational Medicine. The study found that two bnAbs, dubbed VRC01LS and 10-1074, prolonged viral suppression after stopping antiretrovirals, and...
National Cancer Plan: Developing Effective Treatments
This is the fourth in a series of articles about the goals of the National Cancer Institute’s National Cancer Plan, designed to support the aims of President Joe Biden’s Cancer Moonshot initiative to end cancer as we know it. The plan is split into eight goals, one of which is to develop effective treatments. For more, see Part 1: Eliminating Inequities, Part 2: Preventing Cancer and Part 3: Detect Cancers Early.
CDC Calls for Simplified Hepatitis C Testing
Hepatitis C virus (HCV) testing should shift from the current two-step process to one that requires just a single blood draw, making it quicker and easier to identify people who could benefit from treatment, according to updated guidance from the Centers for Disease Control and Prevention (CDC). Estimates suggest that...
Excessive Drinking During the Pandemic Increased Alcoholic Liver Disease Death Rates
Excessive drinking during the COVID-19 pandemic increased alcoholic liver disease deaths so much that the condition killed more Californians than car accidents or breast cancer, a KFF Health News analysis has found. While this led to a rise in all sorts of alcohol-related deaths, the number of Californians dying from...
FDA Approves First Nonprescription Daily Oral Contraceptive
Today [July 13], the U.S. Food and Drug Administration approved Opill (norgestrel) tablet for nonprescription use to prevent pregnancy— the first daily oral contraceptive approved for use in the U.S. without a prescription. Approval of this progestin-only oral contraceptive pill provides an option for consumers to purchase oral contraceptive...
Do diet drinks with aspartame cause cancer?
On July 13, the World Health Organization (WHO) released two reports about aspartame, an artificial sweetener widely used in diet sodas, sugar-free chewing gum and other low-calorie products. (The most popular brand of artificial sweetener, Equal, contains aspartame and usually comes in blue packets, while Sweet ‘N Low, or saccharin, comes in pink, and Splenda, or sucralose, comes in yellow.)
Rates of Fatty Liver Disease Are Rising Worldwide
Non-alcoholic fatty liver disease (NAFLD) has become a leading cause of advanced liver disease and related complications, and rates continue to rise worldwide, according to a pair of recent studies published in the Journal of Hepatology. Arising from the accumulation of fat in the liver, NAFLD and its more severe...
Healthy Recipe: White Bean, Arugula & Tomato Salad
This White Bean, Arugula & Tomato Salad is a great way to get more beans into your summer menus. And you can add so many different fresh herbs to this salad — we’ve named a few good candidates to get you started, so go ahead and pick your favorite combo.
Yes, We Can End AIDS by 2030. A UNAIDS Report Shows How.
Highlighting global progress against the HIV epidemic, a new report from UNAIDS makes the case that it’s possible to end AIDS by 2023. It lays out the steps to reach that goal and clarifies the challenges global regions face in tackling the HIV epidemic. The report states that in...
CDC to Launch Bridge Access Program to Provide Free COVID-19 Vaccines and Treatments
CDC to Launch “Bridge Access Program” in Fall 2023 to Provide Free COVID-19 Vaccines and Treatments to Uninsured and Underinsured Adults. To help ensure that millions of uninsured and underinsured American adults continue to have access to no-cost COVID-19 vaccinations, the Centers for Disease Control and Prevention (CDC) is launching the Bridge Access Program for COVID-19 Vaccines this fall.
Why the Next Big Hope for Alzheimer’s Might Not Help Most Black Patients
The FDA on [July 6] gave full approval to what many scientists and doctors believe is the first drug to show promise of slowing the progression of Alzheimer’s disease. But while patient advocates are celebrating, critics see it as the unfortunate triumph of a flawed theory of the disease’s cause and predict the rollout of the drug will aggravate racial disparities in elder care.
Medicare Proposes Covering All Forms of PrEP to Prevent HIV
The federal government proposes that Medicare cover the cost of all forms of pre-exposure prophylaxis, or PrEP, to prevent HIV, including daily pills and long-acting injectables as well as the related doctor visits and screenings, such as tests for HIV and hepatitis. The Centers for Medicare and Medicaid Services (CMS)...
Even Brief Exercise Boosts Cancer-Fighting Immune Cells
Women with breast cancer experienced increases in cancer-fighting immune cells after a brief period of exercise, according to a recent study published in Nature Scientific Reports. A related study, published in Frontiers in Physiology, saw similar results for people with lymphoma. Both studies showed that a single 10-minute exercise session...
National Cancer Plan: Detect Cancers Early
This is the third in a series of articles about the goals of the National Cancer Institute’s National Cancer Plan, designed to support the aims of President Joe Biden’s Cancer Moonshot initiative to end cancer as we know it. The plan is split into eight goals, one of which is to detect cancers early. For more, see Part 1: Eliminating Inequities and Part 2: Preventing Cancer.
Patients Squeezed in Fight Over Who Gets to Bill for Pricey Infusion Drugs
Health insurers and medical providers are battling over who should supply high-cost infusion drugs for patients, with the tussle over profits now spilling into statehouses across the country. The issue is that some insurers are bypassing hospital pharmacies and physician offices and instead sending more complex drugs through third-party pharmacies....
How Health Care May Be Affected by the High Court’s Affirmative Action Ruling
Doctors are concerned that a Supreme Court ruling issued June 29 will have far-reaching effects not only on the diversity of doctors and other care providers in training but ultimately also on patient care. The decision found it is unconstitutional for colleges and universities to use race as a factor...
Susan Love, MD, Breast Cancer Surgeon and Advocate, Dies at 75
Susan Love, MD, MBA, outspoken lesbian doctor and fierce breast cancer advocate, died at age 75 in her Los Angeles home after a recurrence of leukemia, The New York Times reports. “Founding Mother” and chief visionary officer of the Susan Love Foundation for Breast Cancer Research, Love was a breast...
Misinformation Obscures Standards Guiding Gender-Affirming Care for Trans Youth
Almost three weeks after Florida’s Republican governor, Ron DeSantis, signed a bill making it a felony for doctors to provide gender-affirming care to transgender minors, a judge issued a preliminary injunction preventing enforcement of the law for three children whose parents are part of an ongoing lawsuit. Florida is...
Investigational Three-Month TB Regimen Is Safe but Ineffective
The first clinical trial of a three-month tuberculosis (TB) treatment regimen is closing enrollment because of a high rate of unfavorable outcomes with the investigational course of treatment. AIDS Clinical Trials Group 5362, also known as the CLO-FAST trial, sought to evaluate the safety and efficacy of a three-month clofazimine-...
Real Health
3K+
Posts
12M+
Views
Real Health is the leading health magazine for African Americans in the United States. Launched in 2004, the goal of Real Health is to help African Americans of all ages achieve optimum health and wellness—physically, mentally and emotionally—by offering readers current, accurate information based on the latest science through well-researched stories that educate, entertain, uplift and motivate members of the community at large to be their best selves.
Welcome to NewsBreak, an open platform where diverse perspectives converge. Most of our content comes from established publications and journalists, as well as from our extensive network of tens of thousands of creators who contribute to our platform. We empower individuals to share insightful viewpoints through short posts and comments. It’s essential to note our commitment to transparency: our Terms of Use acknowledge that our services may not always be error-free, and our Community Standards emphasize our discretion in enforcing policies. We strive to foster a dynamic environment for free expression and robust discourse through safety guardrails of human and AI moderation. Join us in shaping the news narrative together.